| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |